WHITEPAPER | PULLAN'S PIECES - A BUSINESS DEVELOPMENT VIEW OF THE ONCOLOGY LANDSCAPE

Pullan's Pieces - A Business Development View of the Oncology Landscape

With an unprecedented number of new investigational agents and companies in today’s oncology space, it can be challenging to track and understand current oncology agents in clinical development, the clinical trials testing them, and what it means for the future.

In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers an insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.
 
In Part I of the three-part series you'll learn :

  • How today’s oncology market compares to other therapeutic areas
  • Unmet needs
  • Who the major players are and what they are developing 
  • What deals are like and the stage of development they are taking place in
  • What we can expect in the upcoming years
This whitepaper is based on a one-hour webinar where Linda provided a comprehensive overview of today’s robust oncology landscape and offered her clarity and perspectives on many of its complexities and nuances.

VIEW THE
WHITEPAPER

ABOUT SHAREVAULT

ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.

guest author:

Company team

Linda Pullan, PhD

Pullan Consulting

Linda and her team at Pullan Consulting offer biotech and pharmaceutical companies consulting in all aspects of partnering. Linda has a PhD in Biochemistry, a BS in Chemistry, and over twenty years of drug industry experience, including work on more than 75 deals. Learn More

IN COLLABORATION WITH:

Demo Logo